| Training set | Validation set |  |
---|---|---|---|
Characters | n = 410(%) | n = 148(%) | P |
Sex | |||
 Male | 327(79.8) | 124 (83.8) | 0.286 |
 Female | 83 (20.2) | 24 (16.2) |  |
Age | |||
 <50 | 91 (22.2) | 25 (16.9) | 0.173 |
  ≥ 50 | 319 (77.8) | 123 (83.1) |  |
Tumor size(cm) | |||
 <3 | 230 (56.1) | 84 (56.8) | 0.212 |
 3–5 | 81 (19.8) | 37 (25.0) |  |
  ≥ 5 | 99 (24.1) | 27 (18.2) |  |
Tumor multiplicity | |||
 Single | 266 (64.9) | 77 (52.0) | 0.006 |
 Multiple | 144 (35.1) | 71 (48.0) |  |
Cirrhosis | |||
 Yes | 377 (92.0) | 135 (91.2) | 0.780 |
 No | 33 (8.0) | 13 (8.8) |  |
PVTT | |||
 Yes | 145 (35.4) | 40 (27.0) | 0.065 |
 N0 | 265 (64.6) | 108 (73.0) |  |
Ascites | |||
 Yes | 162 (39.5) | 53 (35.8) | 0.428 |
 No | 248 (60.5) | 95 (64.2) |  |
HBsAg | |||
 Positive | 330 (78.5) | 120 (81.1) | 0.876 |
 Negative | 80 (21.5) | 28 (18.9) |  |
NLR | |||
 <5 | 344 (83.9) | 132 (89.2) | 0.119 |
  ≥ 5 | 66 (16.1) | 16 (10.8) |  |
HGB(g/L) | |||
 <120 | 159 (38.8) | 58 (39.2) | 0.930 |
  ≥ 120 | 251 (61.2) | 90 (60.8) |  |
PLT(*10^9/L) | |||
 <100 | 219 (53.4) | 80 (54.1) | 0.894 |
  ≥ 100 | 191 (46.6) | 68 (45.9) |  |
CR (μmoI/L) | |||
 <111 | 391 (95.4) | 141 (95.3) | 0.962 |
  ≥ 111 | 19 (4.6) | 7 (4.7) |  |
ALT(U/L) | |||
 <50 | 347 (84.6) | 130 (87.8) | 0.343 |
  ≥ 50 | 63 (15.4) | 18 (12.2) |  |
AST(U/L) | |||
 <40 | 268 (65.4) | 113 (76.4) | 0.014 |
  ≥ 40 | 142 (34.6) | 35 (23.6) |  |
TBIL (μmol/L) | |||
 <18.8 | 218 (53.2) | 87 (58.8) | 0.240 |
  ≥ 18.8 | 192 (46.8) | 61 (41.2) |  |
ALB(g/L) | |||
  < 40 | 275 (67.1) | 103 (69.6) | 0.574 |
  ≥ 40 | 135 (32.9) | 45 (30.4) |  |
LDH(U/L) | |||
 <250 | 365 (89.0) | 131 (88.5) | 0.865 |
  ≥ 250 | 45 (11.0) | 17 (11.5) |  |
GGT (U/L) | |||
 <60 | 273 (66.1) | 99 (66.9) | 0.861 |
  ≥ 60 | 139 (33.9) | 49 (33.1) |  |
PTA (%) | |||
  < 70 | 142 (34.6) | 42 (28.4) | 0.165 |
  ≥ 70 | 268 (65.4) | 106 (71.6) |  |
CEA (ng/ml) | |||
  < 5 | 345 (84.1) | 113 (76.4) | 0.034 |
  ≥ 5 | 65 (15.9) | 35 (23.6) |  |
CA199(u/ml) | |||
  < 37 | 364 (89.3) | 133 (90.5) | 0.664 |
  ≥ 37 | 44 (11.7) | 14 (9.5) |  |
CRP (mg/L) | |||
  < 5 | 266 (64.9) | 99 (71.2) | 0.180 |
  ≥ 5 | 144 (35.1) | 40 (28.8) |  |
Child-Pugh | |||
 A | 230 (56.1) | 92 (62.2) | 0.168 |
 B | 127 (31.0) | 45 (30.4) |  |
 C | 53 (12.9) | 11 (7.4) |  |
BCLC stage | |||
 0-B | 322 (78.5) | 119 (80.4) | 0.632 |
 C-D | 88 (21.5) | 29 (19.6) |  |
ALBI grade | |||
 I | 149 (36.3) | 76 (51.4) | 0.004 |
 II | 207 (50.5) | 59 (39.9) |  |
 III | 56 (13.7) | 13 (8.8) |  |
TNM | |||
 I | 159 (38.8) | 53 (35.8) | 0.005 |
 II | 66 (16.1) | 42 (28.4) |  |
 III | 131 (32.0) | 43 (29.1) |  |
 IV | 54 (13.2) | 10 (6.8) |  |